Navigation Links
Haemonetics Expands Its Blood Management Product Portfolio with Acquisition of SEBRA Business Unit
Date:9/8/2009

nd new technologies for thermal-forming, sealing and welding plastics for medical device manufacturing and biopharmaceutical companies in more than 60 countries."

Based in Tucson, Arizona, Engineering and Research Associates will remain a global company dedicated to the development of innovative technology and quality products for the medical device manufacturing and biopharmaceutical industries. The company will operate under a new company name to be announced later this year. Haemonetics will retain the SEBRA brand and will relocate the SEBRA Blood Collection and Processing Division to its Braintree and Salt Lake City locations.

The SEBRA Blood Collection and Processing business had $10 million in sales in 2008 and has a 10 year compounded annual growth rate for revenues of more than 9%. The acquisition is expected to be neutral to earnings per share in fiscal 2010 and accretive in fiscal 2011.

Haemonetics and Engineering and Research Associates have posted frequently asked questions on Haemonetics' website at http://www.haemonetics.com/site/content/km/factSheet.asp.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web sit
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Haemonetics Sets Date for First Quarter Fiscal Year 2010 Earnings Release: August 3, 2009
2. Haemonetics Shares Success of Outstanding Fiscal 2009 Performance with Employees
3. Haemonetics Sets Date For Fourth Quarter Fiscal Year 2009 Earnings Release: May 4, 2009
4. Haemonetics Sets Date for Investor/Analyst Meeting
5. Haemonetics Expands Its Blood Management Leadership With Acquisition of Neoteric Technology Ltd
6. Haemonetics Announces Change to Board of Directors
7. Haemonetics Bolsters Blood Bank Information Management Portfolio With Acquisition of Altivation Software
8. Haemonetics Reports Double Digit Growth in Revenue, Operating Income, and EPS for the Third Quarter Fiscal 2009
9. Haemonetics to Present at J.P. Morgan Healthcare Conference
10. Dr. Jonathan White Joins Haemonetics as Head of Research and Development
11. Haemonetics Announces Promotion of Brian Concannon to CEO Effective April 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... (PRWEB) September 15, 2014 Insurers ... initiatives that bring providers on board as partners ... satisfaction. When bundled payment programs are designed properly ... incentives, incentivize hospitals to work collaboratively with providers, ... tally. On Sept. 24, the Atlantic Information Services ...
(Date:9/15/2014)... New Jersey, Sept 9, 2014 – New Jersey ... firm of Ricci Tyrrell Johnson & Grey, PLLC, has ... No. 8,774,911 from the United States Patent and Trademark ... locator instrument is invented by Dr. Lee M. Buono ... in minimally-invasive spine surgery. , Precise pedicle location is ...
(Date:9/15/2014)... September 15, 2014 Recently, Top10BestSEOHosting.com ... announced that GreenGeeks ( http://www.greengeeks.com/cgi-bin/affiliates/clickthru.cgi?id=seohosts ), IX Web ... suppliers in 2014. , “These companies have outperformed ... customer support, so that we call them the ... people can get the best web hosting to ...
(Date:9/14/2014)... 14, 2014 When active, the protein ... several human cancers including pancreatic, prostate, lung, colon and ... available. A study published today in the journal Nature ... these Ral proteins: "When you want to keep an ... shut. We took another approach – we put a ...
(Date:9/14/2014)... -- Getting enough sleep each night may mean you,re less likely ... study suggests. The study included more than 3,700 people in ... of seven years. Those who slept less than six hours ... to have extended absences from work due to illness, the investigators ... work due to sickness were those who slept between seven and ...
Breaking Medicine News(10 mins):Health News:Sept. 24 Webinar to Profile Geisinger Health System, BCBS of North Carolina’s Successful Bundled-Payment Programs 2Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 2Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 3Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 4Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 5Health News:Nature: New drug blocks gene driving cancer growth 2Health News:Nature: New drug blocks gene driving cancer growth 3Health News:A Good Night's Sleep May Mean a Good Day's Work 2
... 57 million Americans currently living with "pre-diabetes" could benefit from ... a new study published in this month,s American Journal ... Weight Watchers group program, overweight or obese adults who attended ... lost weight, but also significantly reduced fasting glucose and insulin ...
... Georgia Institute of Technology has received a $100,000 Grand ... Foundation. The grant will support an innovative global health ... in Georgia Tech,s School of Mechanical Engineering, titled "Complement-based ... grants announced by the Gates Foundation in the fourth ...
... successful testing of a sensor that can instantly tell whether ... by emergency room doctors to determine whether a patient has ... diabetics do not take enough insulin. Someday the technology may ... determine whether they need more insulin. A report on the ...
... Through ... and rare diseases are possible before they ever manifest. The future of medicine starts ... (PRWEB) ... world’s first predictive medicine company, is working with healthcare providers to PREDICT, PREVENT, and ...
... ... ... -- IT-Lifeline, the Northwest’s foremost provider of disaster recovery and business continuity solutions, and ... have entered into a joint marketing agreement to provide a suite of Disaster Recovery ...
... fingerroot inhibited production of carcinogenic compounds , THURSDAY, May ... to your burgers before tossing them on the grill ... of the meat, but they can also cut the ... beef. , Scientists at Kansas State University (KSU) found ...
Cached Medicine News:Health News:New study finds attending Weight Watchers meetings helps reduce the risk for type 2 diabetes 2Health News:Georgia Tech awarded Gates Foundation grant for innovative global health research 2Health News:Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease 2Health News:Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease 3Health News:IT-Lifeline, Inc and OptiStor Technologies, Inc. Enter Joint Marketing Agreement 2Health News:IT-Lifeline, Inc and OptiStor Technologies, Inc. Enter Joint Marketing Agreement 3Health News:Some Spices Cut Cancer Risk That Comes With Grilled Burgers 2
(Date:9/14/2014)... 2014  Abbott announced today positive one-year clinical ... randomized, controlled trial comparing the safety and effectiveness ... market-leading metallic XIENCE family of DES.  The trial, ... included 501 people with coronary artery disease (CAD), ... results were featured at a late-breaking session at ...
(Date:9/12/2014)... Colorado eye care provider Vision Care Specialists announced expansion ... high quality eye care services. Photo - http://photos.prnewswire.com/prnh/20140912/145684 ... locations in Aurora , Lakewood ... days a week. Hours are Monday, Tuesday, Thursday and Friday 7:45 ... Saturday 7:45 AM to 2:30 PM. The downtown Denver ...
(Date:9/12/2014)...   Synthetic Biologics, Inc. (NYSE MKT: ... and drug programs targeting specific pathogens that cause ... U.S. Food and Drug Administration (FDA) has granted ... monoclonal antibody (mAb) combination for the treatment of ... the U.S., Orphan Drug Designation provides a variety ...
Breaking Medicine Technology:ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 2ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 3ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 4ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 5Colorado Eye Care: Vision Care Specialists Expands Hours, adds Optometrists to Denver Locations 2Colorado Eye Care: Vision Care Specialists Expands Hours, adds Optometrists to Denver Locations 3Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis) 2Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis) 3
... and Efficacy Data Reported ... Enrollment Advancing Ahead of Schedule, SOUTH SAN FRANCISCO, ... ) today presented an update of interim,data from the ... product,candidate, voreloxin (formerly SNS-595), in platinum-resistant ovarian,cancer patients at ...
... Results Confirm Previously Demonstrated Survival Advantages of Tarceva in ... This Difficult-to-Treat Disease ... - ABSTRACT No: 4507, ... Tarceva (erlotinib) and chemotherapy significantly,improves the time patients with metastatic pancreatic cancer ...
Cached Medicine Technology:Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 2Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 3Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 4Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 5Patients with Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R) 2Patients with Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R) 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: